Clinical Trial Update: The Effect of Nexium on Transmucosal Esophageal Leak [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating whether Nexium (esomeprazole) affects transmucosal esophageal leak. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: Main Line Health | Conditions: Reflux, Esophagitis | Phase 1 | Status: UNKNOWN